Download Files:

D-Cycloserine

$60$70

Products Details

Product Description

– D-Cycloserine is an antibiotic which targets sequential bacterial cell wall peptidoglycan biosynthesis enzymes. D-Cycloserine is a partial NMDA agonist that can improve cognitive functions. D-Cycloserine can be used for multidrug-resistant tuberculosis research[1][2].

Web ID

– HY-B0030

Storage Temperature

– -20°C, 3 years; 4°C, 2 years (Powder)

Shipping

– Room Temperature

Applications

– COVID-19-immunoregulation

Molecular Formula

– C3H6N2O2

References

– [1]Sarah Batson, et al. Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine. Nat Commun. 2017 Dec 5;8(1):1939.|[2]Nitsche, M.A., et al., Consolidation of human motor cortical neuroplasticity by D-cycloserine. Neuropsychopharmacology, 2004. 29(8): p. 1573-8.|[3]Levin, E.D., et al., D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response. Pharmacol Biochem Behav, 2011. 98(2): p. 210-4.

CAS Number

– 68-41-7

Molecular Weight

– 102.09

Compound Purity

– 99.97

SMILES

– O=C1[C@H](N)CON1

Clinical Information

– Launched

Research Area

– Infection; Neurological Disease; Cancer

Solubility

– DMSO : 1 mg/mL (warming)|H2O : 25 mg/mL (ultrasonic)

Target

– Antibiotic;Bacterial;iGluR

Isoform

– NMDA Receptor

Pathway

– Anti-infection;Membrane Transporter/Ion Channel;Neuronal Signaling

Product type

– Natural Products

Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.